Octaplaslg for white house medical unit
Ended Purchase Order Awarded
- Contract number
- HT942525P0074
- Awardee
-
Octapharma USA Inc. UEI FKJKNJVR1HV4
- Awarding agency
-
Defense Health Agency
Department of Defense
- Obligated
- $100,000
Award facts
- Opportunity
-
- HT942525T0003 Solicitation number
- Contract value 100% obligated
- $100,000.00 Current and potential, with all options
- Completion date 100% complete
- Current and potential, with all options
- Contracting staff
- NAICS code
- 325414 Biological Product (except Diagnostic) Manufacturing
- PSC
- 6505 Drugs And Biologicals
- Set-aside
- No set-aside
- Competition
- Not Competed · 1 offer Only One Source
- Pricing
- Firm Fixed Price
- Place of performance
- Germany
Award details come from SAM.gov/FPDS.
About this award
This is a firm fixed-price purchase order awarded by the Defense Health Agency, a defense agency, to Octapharma USA Inc., a foreign-owned, for-profit manufacturer of goods, for the provision of OCTAPLASLG for the White House Medical Unit. The contract has a ceiling value of $100,000.00 and a period of performance ending on June 8, 2025. There is no set-aside designation mentioned. The award was made on May 23, 2025.
Quick answers
Who was awarded contract HT942525P0074?
HT942525P0074 was awarded to Octapharma USA Inc. by Defense Health Agency (Department of Defense) on May 23, 2025.
How much is contract HT942525P0074 worth?
The government has obligated $100,000 on HT942525P0074.
Was contract HT942525P0074 competed?
The extent of competition for HT942525P0074 was not competed. The government received 1 offer.
On GovTribe
See this award's full record
- Every transaction and funding action
- The awardee's other awards and teaming partners
- Similar awards and recompete opportunities
- Ask GovTribe AI about this award